Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in
BRCA
breast cancer
meta-analysis
risk-reducing salpingo-oophorectomy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
06 Mar 2023
06 Mar 2023
Historique:
received:
11
01
2023
revised:
20
02
2023
accepted:
02
03
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
Risk-reducing salpingo-oophorectomy (RRSO) is the gold standard method of ovarian cancer risk reduction, but the data are conflicting regarding the impact on breast cancer (BC) outcomes. This study aimed to quantify BC risk/mortality in We conducted a systematic review (CRD42018077613) of RRSO was not associated with a significant reduction in the PBC risk (RR = 0.84, 95%CI: 0.59-1.21) or CBC risk (RR = 0.95, 95%CI: 0.65-1.39) in RRSO was not associated with PBC or CBC risk reduction in
Sections du résumé
BACKGROUND
BACKGROUND
Risk-reducing salpingo-oophorectomy (RRSO) is the gold standard method of ovarian cancer risk reduction, but the data are conflicting regarding the impact on breast cancer (BC) outcomes. This study aimed to quantify BC risk/mortality in
METHODS
METHODS
We conducted a systematic review (CRD42018077613) of
RESULTS
RESULTS
RRSO was not associated with a significant reduction in the PBC risk (RR = 0.84, 95%CI: 0.59-1.21) or CBC risk (RR = 0.95, 95%CI: 0.65-1.39) in
CONCLUSIONS
CONCLUSIONS
RRSO was not associated with PBC or CBC risk reduction in
Identifiants
pubmed: 36900415
pii: cancers15051625
doi: 10.3390/cancers15051625
pmc: PMC10001253
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Rosetrees Trust
ID : CF1\100001
Organisme : Barts Charity
ID : ECMG1C3R
Références
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
J Med Genet. 2000 Nov;37(11):866-74
pubmed: 11073541
BMC Cancer. 2008 May 30;8:155
pubmed: 18513387
J Clin Oncol. 2000 Nov 1;18(21 Suppl):100S-3S
pubmed: 11060335
J Clin Oncol. 2004 Mar 15;22(6):1055-62
pubmed: 14981104
Medicina (Kaunas). 2022 Jul 17;58(7):
pubmed: 35888662
J Natl Cancer Inst. 2019 Mar 1;111(3):331-334
pubmed: 30496449
Clin Breast Cancer. 2007 Dec;7(11):875-82
pubmed: 18269778
JAMA Oncol. 2021 Apr 01;7(4):585-592
pubmed: 33630024
Breast Cancer Res Treat. 2011 May;127(1):287-96
pubmed: 21221768
Br J Cancer. 2005 Aug 8;93(3):287-92
pubmed: 16052221
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:46-65
pubmed: 32192936
Clin Genet. 2010 Apr;77(4):342-9
pubmed: 20059483
Breast Cancer Res Treat. 2014 Apr;144(3):443-55
pubmed: 24567198
Gynecol Oncol. 2017 Apr;145(1):122-129
pubmed: 28190649
Genet Med. 2008 Mar;10(3):161-166
pubmed: 18344704
JAMA. 2006 Jul 12;296(2):185-92
pubmed: 16835424
N Engl J Med. 2002 May 23;346(21):1616-22
pubmed: 12023993
Eur J Cancer. 2003 May;39(7):861-9
pubmed: 12706354
J Natl Cancer Inst. 1999 Sep 1;91(17):1475-9
pubmed: 10469748
J Clin Oncol. 2007 Apr 10;25(11):1329-33
pubmed: 17416853
J Clin Oncol. 2008 Mar 10;26(8):1331-7
pubmed: 18268356
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Ann Oncol. 2006 Mar;17(3):391-400
pubmed: 16322115
J Clin Oncol. 2007 Jul 10;25(20):2921-7
pubmed: 17617523
J Clin Epidemiol. 2011 Dec;64(12):1294-302
pubmed: 21803546
Breast Cancer Res Treat. 2014 Nov;148(2):397-406
pubmed: 25311111
Lancet. 2000 Jun 10;355(9220):2015-20
pubmed: 10885351
Cochrane Database Syst Rev. 2018 Aug 24;8:CD012464
pubmed: 30141832
JAMA. 2019 Sep 3;322(9):868-886
pubmed: 31479143
Cancer. 2012 Jan 15;118(2):510-7
pubmed: 21717445
Lancet Oncol. 2006 Oct;7(10):821-8
pubmed: 17012044
Gynecol Oncol. 2018 Jul;150(1):79-84
pubmed: 29735278
J Clin Oncol. 2012 Apr 20;30(12):1321-8
pubmed: 22430266
Eur J Cancer. 2015 Feb;51(3):400-8
pubmed: 25532426
BJOG. 2022 Jan;129(1):e16-e34
pubmed: 34672090
Menopause. 2009 Jan-Feb;16(1):15-23
pubmed: 19034050
Lancet. 2013 May 25;381(9880):1827-34
pubmed: 23639488
J Med Genet. 2022 Feb;59(2):122-132
pubmed: 33568437
Breast Cancer Res Treat. 2019 Oct;177(3):723-733
pubmed: 31302855
JAMA. 2010 Sep 1;304(9):967-75
pubmed: 20810374
J Natl Cancer Inst. 2009 Jan 21;101(2):80-7
pubmed: 19141781
Clin Breast Cancer. 2018 Dec;18(6):e1361-e1366
pubmed: 30122348
Lancet Oncol. 2006 Mar;7(3):223-9
pubmed: 16510331
Fam Cancer. 2015 Dec;14(4):531-8
pubmed: 26239694
Cancer. 2011 Jun 15;117(12):2659-67
pubmed: 21656744
Hum Reprod. 2007 Jun;22(6):1573-7
pubmed: 17428877
Breast Cancer Res. 2020 Jan 16;22(1):8
pubmed: 31948486
Fam Cancer. 2012 Sep;11(3):403-10
pubmed: 22477030
J Natl Cancer Inst. 2003 Jul 2;95(13):941-7
pubmed: 12837830
Prev Med. 2000 Jul;31(1):75-80
pubmed: 10896846
J Natl Cancer Inst. 2015 Mar 18;107(5):
pubmed: 25788320
J Clin Oncol. 2005 Dec 1;23(34):8629-35
pubmed: 16314625
J Clin Oncol. 2005 Oct 20;23(30):7491-6
pubmed: 16234515
Lancet. 2020 Jan 11;395(10218):117-122
pubmed: 31839281
J Clin Oncol. 2004 Jun 15;22(12):2328-35
pubmed: 15197194
Breast Cancer Res Treat. 2013 Jul;140(1):135-42
pubmed: 23784379
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1089-96
pubmed: 22564871
J Genet Couns. 2005 Dec;14(6):473-84
pubmed: 16388328
Cancers (Basel). 2023 Jan 24;15(3):
pubmed: 36765666
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22
pubmed: 23628597
Obstet Gynecol. 2013 Apr;121(4):709-716
pubmed: 23635669
Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):740-6
pubmed: 17416765
Int J Gynecol Cancer. 2021 Feb;31(2):286-291
pubmed: 32907814
Gynecol Oncol. 2014 May;133(2):283-6
pubmed: 24582866
BJOG. 2012 Apr;119(5):527-36
pubmed: 22260402
J Natl Cancer Inst. 2016 Sep 06;109(1):
pubmed: 27601060
Cancer. 2017 Jul 1;123(13):2497-2505
pubmed: 28182268
World J Surg. 2010 Jul;34(7):1416-26
pubmed: 20182723
Breast Cancer Res Treat. 2019 Jun;175(2):443-449
pubmed: 30756284
BJOG. 2011 Jun;118(7):814-24
pubmed: 21392246
Menopause. 2006 Mar-Apr;13(2):265-79
pubmed: 16645540
Open Med. 2007 Aug 13;1(2):e92-8
pubmed: 20101300
Breast J. 2016 Jan-Feb;22(1):35-44
pubmed: 26695813
Am J Med Genet A. 2003 Apr 30;118A(3):201-9
pubmed: 12673648
J Clin Oncol. 2013 Sep 10;31(26):3191-6
pubmed: 23940229
J Natl Cancer Inst. 2015 Aug 11;107(9):
pubmed: 26264691
Breast Cancer Res Treat. 2002 May;73(2):97-112
pubmed: 12088120
Fam Cancer. 2006;5(4):327-35
pubmed: 16724248
Genet Test Mol Biomarkers. 2009 Feb;13(1):51-6
pubmed: 19309274
Br J Cancer. 2011 Apr 26;104(9):1384-92
pubmed: 21487411
Gynecol Oncol. 2002 Aug;86(2):212-9
pubmed: 12144830
J Natl Cancer Inst. 2004 Aug 18;96(16):1204-7
pubmed: 15316055
Cancer. 2006 Dec 15;107(12):2745-51
pubmed: 17109443
Gynecol Oncol. 2015 Sep;138(3):723-6
pubmed: 26086567
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2318-24
pubmed: 19661091
J Clin Oncol. 2005 Oct 1;23(28):6890-8
pubmed: 16129845
J Cancer Res Clin Oncol. 2016 Jan;142(1):333-40
pubmed: 26438354
Menopause Int. 2008 Sep;14(3):111-6
pubmed: 18714076
JAMA Oncol. 2015 Jun;1(3):306-13
pubmed: 26181175
N Engl J Med. 2002 May 23;346(21):1609-15
pubmed: 12023992
PLoS One. 2017 Jan 6;12(1):e0169673
pubmed: 28060958
Clin Breast Cancer. 2019 Feb;19(1):e48-e65
pubmed: 30470623
Cochrane Database Syst Rev. 2020 Mar 6;3:CD013538
pubmed: 32141074
J Ovarian Res. 2016 Feb 29;9:11
pubmed: 26928677
Neurology. 2008 Jan 15;70(3):200-9
pubmed: 17761549
J Med Genet. 2022 Feb;59(2):133-140
pubmed: 33568438
Lancet. 2015 Nov 7;386(10006):1845-52
pubmed: 26318519
Am J Hum Genet. 2003 May;72(5):1117-30
pubmed: 12677558
Neurology. 2007 Sep 11;69(11):1074-83
pubmed: 17761551